ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
IDEAYA Biosciences Submits IND Application for MAT2A Development Candidate IDE397
January 15, 2021IDEAYA Biosciences has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial to evaluate IDE397, a small molecule methionine adenosyltransferase 2a ... -
IDEAYA Biosciences and Cancer Research UK Announce Partnership Agreement to Develop Small Molecule I
March 14, 2018IDEAYA Biosciences announced today that it has entered into a cooperation agreement with the UK-based Cancer Research Corporation (CRUK) Business Collaboration Team and the Drug Discovery Department of the Manchester Institute at the University of Manches
Pharma Sources Insight January 2025
